Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, François Philippart
Topics & Concepts
TocilizumabMedicineImmunologyIntensive care medicinePharmacotherapyCoronavirus disease 2019 (COVID-19)Immune systemInternal medicineInfectious disease (medical specialty)DiseaseRheumatoid arthritisCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Respiratory Support and Mechanisms